X바이오테크 (XBIT) 주가

X바이오테크(XBIT)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $2.19 (+1.39%), 시가총액 $77.74M, 52주 범위 $2.12 ~ $3.50.

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

핵심 지표

• 현재가: $2.19 (+1.39%)
• 시가총액: $77.74M
• 52주 최저~최고: $2.12 ~ $3.50
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NAS

X바이오테크의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

X바이오테크 재무 요약

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.55
• 순이익률: 0.00%
• 영업이익률: 0.00%

자주 묻는 질문